Literature DB >> 6150407

[Crohn disease: I. Possibilities and limits of conservative therapy].

W Domschke.   

Abstract

As the etiology of Crohn's disease is still unknown, medical as well as surgical treatment has to be symptomatic. Medical therapy is performed by use of prednisolone, salazosulfapyridine, metronidazole and elementary diet depending on the localisation and extension of the disease. Surgical treatment means therapy of complications like stenoses, fistulae and abscess formation. Neither after medical nor after surgical treatment the source of the disease is predictable.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6150407     DOI: 10.1007/BF01823248

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  15 in total

1.  [Crohn's disease: course and prognosis in 169 patients (author's transl)].

Authors:  M Mörl; H G Zöberlein; M Classen
Journal:  Dtsch Med Wochenschr       Date:  1978-08-25       Impact factor: 0.628

2.  [Life expectancy in Crohn disease].

Authors:  H Malchow; U Riker; K Dietz
Journal:  Lebensversicher Med       Date:  1981-02-12

3.  Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study.

Authors:  P A Van Hees; H J Van Lier; P H Van Elteren; M Driessen; R A Van Hogezand; G P Ten Velde; J H Bakker; J H Van Tongeren
Journal:  Gut       Date:  1981-05       Impact factor: 23.059

4.  National Cooperative Crohn's Disease Study: results of drug treatment.

Authors:  R W Summers; D M Switz; J T Sessions; J M Becktel; W R Best; F Kern; J W Singleton
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

5.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

6.  The prognosis of inflammatory bowel disease.

Authors:  D J Sales; J B Kirsner
Journal:  Arch Intern Med       Date:  1983-02

7.  Crohn's disease and pregnancy.

Authors:  R Khosla; C P Willoughby; D P Jewell
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

8.  European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.

Authors:  H Malchow; K Ewe; J W Brandes; H Goebell; H Ehms; H Sommer; H Jesdinsky
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

9.  Short-term course and prognosis of Crohn's disease.

Authors:  F T De Dombal; I L Burton; S E Clamp; J C Goligher
Journal:  Gut       Date:  1974-06       Impact factor: 23.059

10.  Treatment of Crohn's disease with peroral 5-aminosalicylic acid.

Authors:  S N Rasmussen; V Binder; K Maier; S Bondesen; C Fischer; U Klotz; S H Hansen; E F Hvidberg
Journal:  Gastroenterology       Date:  1983-12       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.